The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Metabolic engineering for drug discovery and development
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence
Cole, S. T., Brosch, R., Parkhill, J., Garnier, T., Churcher, C., Harris, D., Gordon, S. V., Eiglmeier, K., Gas, S., Barry, C. E., et al. (1998) · Nature · doi:10.1038/31159 · Cited by 7,847
The complete genome sequence of the gram-positive bacterium Bacillus subtilis.
Kunst, F., Ogasawara, N., Moszer, I., Albertini, A. M., Alloni, G., Azevedo, V., Bertero, M. G., Bessières, P., Bolotin, A., Borchert, S., et al. (1997) · Nature · doi:10.1038/36786 · Cited by 3,679
Isoprenoid biosynthesis: The evolution of two ancient and distinct pathways across genomes
Lange, B. M., Rujan, T., Martin, W., & Croteau, R. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.240454797 · Cited by 881
Cited by
The evolving role of natural products in drug discovery
Koehn, F. E., & Carter, G. T. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1657 · Cited by 2,572
Non-fermentative pathways for synthesis of branched-chain higher alcohols as biofuels
Atsumi, S., Hanai, T., & Liao, J. C. (2008) · Nature · doi:10.1038/nature06450 · Cited by 1,945
Programming cells by multiplex genome engineering and accelerated evolution
Wang, H. H., Isaacs, F. J., Carr, P. A., Sun, Z. Z., Xu, G., Forest, C. R., & Church, G. M. (2009) · Nature · doi:10.1038/nature08187 · Cited by 1,529
Synthetic protein scaffolds provide modular control over metabolic flux
Dueber, J. E., Wu, G. C., Malmirchegini, G. R., Moon, T. S., Petzold, C. J., Ullal, A. V., Prather, K. L. J., & Keasling, J. D. (2009) · Nature Biotechnology · doi:10.1038/nbt.1557 · Cited by 1,242
Self-citationBenner, S. A., & Sismour, A. M. (2005) · Nature Reviews Genetics · doi:10.1038/nrg1637 · Cited by 834
Neurotoxic Alkaloids: Saxitoxin and Its Analogs
Wiese, M., D’Agostino, P. M., Mihali, T. K., Moffitt, M. C., & Neilan, B. A. (2010) · Marine Drugs · doi:10.3390/md8072185 · Cited by 769
Lee, S. K., Chou, H., Ham, T. S., Lee, T. S., & Keasling, J. D. (2008) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2008.10.014 · Cited by 616
Self-citationCombinatorial engineering of intergenic regions in operons tunes expression of multiple genes
Pfleger, B. F., Pitera, D. J., Smolke, C. D., & Keasling, J. D. (2006) · Nature Biotechnology · doi:10.1038/nbt1226 · Cited by 536
Self-citationQuantitative1H NMR: Development and Potential of a Method for Natural Products Analysis
Pauli, G. F., Jaki, B. U., & Lankin, D. C. (2005) · Journal of Natural Products · doi:10.1021/np0497301 · Cited by 518
BglBrick vectors and datasheets: A synthetic biology platform for gene expression
Lee, T. S., Krupa, R. A., Zhang, F., Hajimorad, M., Holtz, W. J., Prasad, N., Lee, S. K., & Keasling, J. D. (2011) · Journal of Biological Engineering · doi:10.1186/1754-1611-5-12 · Cited by 476
Self-citationTerpenoids: Opportunities for Biosynthesis of Natural Product Drugs Using Engineered Microorganisms
Ajikumar, P. K., Tyo, K., Carlsen, S., Mucha, O., Phon, T. H., & Stephanopoulos, G. (2008) · Molecular Pharmaceutics · doi:10.1021/mp700151b · Cited by 447
Synthetic Biology for Synthetic Chemistry
Keasling, J. D. (2008) · ACS Chemical Biology · doi:10.1021/cb7002434 · Cited by 409
Self-citationProduction of isoprenoid pharmaceuticals by engineered microbes
Chang, M. C. Y., & Keasling, J. D. (2006) · Nature Chemical Biology · doi:10.1038/nchembio836 · Cited by 387
Self-citationProgrammable ligand-controlled riboregulators of eukaryotic gene expression
Bayer, T. S., & Smolke, C. D. (2005) · Nature Biotechnology · doi:10.1038/nbt1069 · Cited by 376
A Yeast Synthetic Network for In Vivo Assessment of Reverse-Engineering and Modeling Approaches
Cantone, I., Marucci, L., Iorio, F., Ricci, M. A., Belcastro, V., Bansal, M., Santini, S., di Bernardo, M., di Bernardo, D., & Cosma, M. P. (2009) · Cell · doi:10.1016/j.cell.2009.01.055 · Cited by 376
Production and engineering of terpenoids in plant cell culture
Roberts, S. C. (2007) · Nature Chemical Biology · doi:10.1038/nchembio.2007.8 · Cited by 371
Beld, J., Sonnenschein, E. C., Vickery, C. R., Noel, J. P., & Burkart, M. D. (2014) · Nat. Prod. Rep. · doi:10.1039/c3np70054b · Cited by 357
Exploring the diversity of complex metabolic networks
Hatzimanikatis, V., Li, C., Ionita, J. A., Henry, C. S., Jankowski, M. D., & Broadbelt, L. J. (2005) · Bioinformatics · doi:10.1093/bioinformatics/bti213 · Cited by 349
Xu, P., Ranganathan, S., Fowler, Z. L., Maranas, C. D., & Koffas, M. A. G. (2011) · Metabolic Engineering · doi:10.1016/j.ymben.2011.06.008 · Cited by 346
Rocha, J., Peixe, L., Gomes, N. C. M., & Calado, R. (2011) · Marine Drugs · doi:10.3390/md9101860 · Cited by 274
Antiviral Lead Compounds from Marine Sponges
Sagar, S., Kaur, M., & Minneman, K. P. (2010) · Marine Drugs · doi:10.3390/md8102619 · Cited by 259
Model-driven evaluation of the production potential for growth-coupled products of Escherichia coli
Feist, A. M., Zielinski, D. C., Orth, J. D., Schellenberger, J., Herrgard, M. J., & Palsson, B. Ø. (2010) · Metabolic Engineering · doi:10.1016/j.ymben.2009.10.003 · Cited by 238
Chen, T., Wang, J., Yang, R., Li, J., Lin, M., & Lin, Z. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016228 · Cited by 81
Metadata
- Authors
- Khosla, C., & Keasling, J. D.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2003-12-01
- Volume
- 2
- Issue
- 12
- Pages
- 1019-1025
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W1491585327
- Cited by
- 207
- References
- 3
- FWCI
- 0.50
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.